elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q58101062-0A852970-9ADC-49B8-A390-EB71FECEC1C9
Q58101062-0A852970-9ADC-49B8-A390-EB71FECEC1C9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58101062-0A852970-9ADC-49B8-A390-EB71FECEC1C9
The Negishi Cross-Coupling in the Synthesis of Natural Products and Bioactive Molecules
P2860
Q58101062-0A852970-9ADC-49B8-A390-EB71FECEC1C9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58101062-0A852970-9ADC-49B8-A390-EB71FECEC1C9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dfd13971212df809f38df0e7ae728032f045cd0c
P2860
Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTID